AGIO : Summary for Agios Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Agios Pharmaceuticals, Inc. (AGIO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
50.36+2.54 (+5.31%)
At close: 4:00PM EST
People also watch
BLUEKITEJUNOCLVSEPZM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close47.82
Open47.63
Bid48.00 x 200
Ask53.50 x 500
Day's Range47.51 - 50.56
52 Week Range34.31 - 67.74
Volume634,664
Avg. Volume846,378
Market Cap2.13B
Beta2.33
PE Ratio (TTM)-9.93
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Agios Pharmaceuticals, Inc. :AGIO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017
    Capital Cube6 days ago

    Agios Pharmaceuticals, Inc. :AGIO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017

    Categories: Yahoo Finance Get free summary analysis Agios Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Agios Pharmaceuticals, Inc. – Pfizer Inc., Eli Lilly and Company, Alexion Pharmaceuticals, Inc., Celgene Corporation and GlaxoSmithKline plc Sponsored ADR (PFE-US, LLY-US, ALXN-US, CELG-US and GSK-US) that have ... Read more (Read more...)

  • Investopedia10 days ago

    Agios Pharmaceuticals 4Q Loss $1.48 Per Share

    Agios 4Q loss beat Wall Street loss expectations.

  • Agios Pharmaceuticals, Inc. :AGIO-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017
    Capital Cube10 days ago

    Agios Pharmaceuticals, Inc. :AGIO-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017

    Categories: Yahoo Finance Get free summary analysis Agios Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Agios Pharmaceuticals, Inc. – Pfizer Inc., Eli Lilly and Company, Celgene Corporation and GlaxoSmithKline plc Sponsored ADR (PFE-US, LLY-US, CELG-US and GSK-US) that have also reported for this ... Read more (Read more...)